Why is the state of MedTech culture and tools the way it is? How should the industry be thinking about moving away from generic compliance and toward MedTech Lifecycle Excellence?
Jon Bergsteinsson, co-founder of SMART-TRIAL by Greenlight Guru, is a MedTech professional and clinical affairs expert. Jon is also involved in educating and helping the MedTech industry get safe and effective devices to market faster and more efficiently.
Listen to the episode to learn more about how MedTech is different from pharmaceuticals and other similar fields in the industry, why it\u2019s important to look at the entire lifecycle of a medical device, and where the MedTech industry is going.
\u201cWhen you start working in MedTech, and you have experience from other parts of the life science industry, you start to realize how different it is from pharmaceuticals and other similar product developments like biotech, for example.
\u201cIt\u2019s easier to innovate medical device technology.\u201d
\u201cEase of use has a lot to do with the fact that you haven\u2019t involved your end users well enough, or you haven\u2019t involved the right end users.\u201d
\u201cWhen it really comes down to it, you can\u2019t really help or facilitate growth and development in the industry without experiences and insights from other industries.\u201d